A novel and simple cardiac magnetic resonance score (PE2RT) predicts outcome in takotsubo syndrome - Top-Institutions - MDSpire

A novel and simple cardiac magnetic resonance score (PE2RT) predicts outcome in takotsubo syndrome

  • By

  • Alexander Isaak

  • Johanna Bratz

  • Dmitrij Kravchenko

  • Narine Mesropyan

  • Irina Eckardt

  • Leon M. Bischoff

  • Leonie Weinhold

  • Daniel Kuetting

  • Claus Christian Pieper

  • Ulrike Attenberger

  • Sebastian Zimmer

  • Julian A. Luetkens

  • March 23, 2023

  • 0 min

Share

Top Institutions in Radiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Cardiovascular Imaging
    • Heart Failure

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Cardiovascular Imaging
    • Heart Failure

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Cardiovascular Imaging
    • Heart Failure

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Cardiovascular Imaging
    • Heart Failure

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Cardiovascular Imaging
    • Heart Failure

Original Source(s)

A novel and simple cardiac magnetic resonance score (PE2RT) predicts outcome in takotsubo syndrome

  • by Alexander Isaak, Johanna Bratz, Dmitrij Kravchenko, Narine Mesropyan, Irina Eckardt, Leon M. Bischoff, Leonie Weinhold, Daniel Kuetting, Claus Christian Pieper, Ulrike Attenberger, Sebastian Zimmer, Julian A. Luetkens

  • March 23, 2023

Related Content

Quantitative CT assessment of intrathoracic visceral fat depots and their association with incident heart failure in asymptomatic adults

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Respiratory viral infections today, heart failure tomorrow: implications for prevention